Articles tagged "Dystonia: Treatment"

2019 International Congress
High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy
S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)
Objective: To assess safety, therapeutic response and long-term benefit of higher dose Onabotulinum toxin A (OnaA). Background: Botulinum toxin therapy is a powerful tool for…
2019 International Congress
Bilateral Globus pallidus interna Deep Brain Stimulation in Cranio-Cervical Dystonia (Meige syndrome) patient in Hong Kong
C. Lau, C. Zhu, D. Chan, K. Ma, L. Au, A. Chan, R. Wong, J. Yeung, W. Poon, V. Mok (Hong Kong, Hong Kong)
Objective: To report the first cranio- cervical dystonia (Meige syndrome) patient who received Deep Brain Stimulation (DBS) implant in Hong Kong. Background: Meige syndrome is…
2019 International Congress
Rapid improvement in dystonia after pallidal deep brain stimulation in a patient with myoclonus-dystonia syndrome: A case report
L. Deuel, J. Thompson, L. Kahn, J. Barr, A. Abosch, D. Kern (Aurora, CO, USA)
Objective: Describe the time course of clinical response to bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) in a patient with myoclonus-dystonia syndrome (M-D),…
2019 International Congress
Safety of Iron Chelation in Patients with Brain Iron Overload
C. Fradette, T. Klopstock, L. Neumayr, I. Karin, G. Zorzi, T. Kmieć, B. Büchner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, F. Zibordi, N. Nardocci, A. Stilman, M. Spino, E. Vichinsky, F. Tricta (Toronto, ON, Canada)
Objective: To assess the safety of iron chelation in the treatment of regional brain iron overload. Background: Excess brain iron is evident in neurodegenerative diseases…
2019 International Congress
Pediatric Deep Brain Stimulation in Secondary Dystonia using Stereotactic Depth Electrode Targeting
M. Liker, T. Sanger (Los Angeles, CA, USA)
Objective: The primary objective of our pediatric clinical research is to improve outcomes after deep brain stimulation for pediatric patients with secondary dystonia. We apply…
2019 International Congress
Successful treatment of secondary dystonia with deep brain stimulation of the globus pallidus internus
S. Hendrickx, PH. Bourgeois, A. Tieleman, D. Vanhauwaert, T. Couvreur, O. van Damme (Roeselare, Belgium)
Objective: Improving targeting accuracy in the treatment of secondary dystonia with DBS of GPi Background: Dystonia is a very disabling disease. Deep brain stimulation (DBS) of…
2019 International Congress
Benefit and Weakness with botulinum toxin: time course and relationship.
P. Kassavetis, K. Alter, C. Lungu, B. Karp (Bathesda, MD, USA)
Objective: To compare the timecourse of and relationship between benefit and weakness after botulinum toxin (BoNT) injection. Background: The timecourse of benefit onset and duration…
2019 International Congress
GPi DBS does not affect sensory thresholds in hereditary/idiopathic dystonia
C. Listik, R. Gisbert Cury, V. da Silva, S. Carvalho Barbosa Casagrande, E. Listik, L. Link, R. Galhardoni, E. Reis Barbosa, M. Jacobsen Teixeira, D. de Andrade (Sao Paulo, Brazil)
Objective: Despite the widespread use of DBS for dystonia, little is known about its effects on non-motor symptoms such as dystonia-related pain. Here we provide…
2019 International Congress
Impact of pallidal deep brain stimulation on activities of daily living in patients with craniocervical dystonia – a multi-center survey
J. Huebl, T. Andermann, C. Blahak, J. Krauss, M. Südmeyer, J. Volkmann, K. Bötzel, A. Wolters, A. Kühn (Berlin, Germany)
Objective: To assess the impact of pallidal deep brain stimulation (DBS) on activities of daily living (ADL) in patients with primary craniocervical dystonia (CD). Background:…
2019 International Congress
Clinical hypnosis in functional movement disorders: a potential therapeutic strategy
C. Buiza-Aguado, C. Ordas-Bandera, M. Guillan-Rodriguez, J. Del Val, PJ. Garcia Ruiz-Espiga, JC. Martinez-Castrillo, I. Parees-Moreno, A. Alonso-Canovas (Madrid, Spain)
Objective: To present a patient with a functional movement disorder who was successfully treated with clinical hypnosis. Background: Functional movement disorders (FMD), specially fixed dystonia,…